CA2586946C - Nutrition containing fat blend - Google Patents

Nutrition containing fat blend Download PDF

Info

Publication number
CA2586946C
CA2586946C CA2586946A CA2586946A CA2586946C CA 2586946 C CA2586946 C CA 2586946C CA 2586946 A CA2586946 A CA 2586946A CA 2586946 A CA2586946 A CA 2586946A CA 2586946 C CA2586946 C CA 2586946C
Authority
CA
Canada
Prior art keywords
lipid
dha
dpan
total weight
epa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2586946A
Other languages
English (en)
French (fr)
Other versions
CA2586946A1 (en
Inventor
Bernd Stahl
Guenther Boehm
Christopher Beermann
Johan Garssen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nutricia NV
Original Assignee
Nutricia NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34927339&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2586946(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutricia NV filed Critical Nutricia NV
Publication of CA2586946A1 publication Critical patent/CA2586946A1/en
Application granted granted Critical
Publication of CA2586946C publication Critical patent/CA2586946C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/22Comminuted fibrous parts of plants, e.g. bagasse or pulp
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pediatric Medicine (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Edible Oils And Fats (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Seeds, Soups, And Other Foods (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Dairy Products (AREA)
  • Medicinal Preparation (AREA)
  • Fats And Perfumes (AREA)
CA2586946A 2004-11-11 2005-11-11 Nutrition containing fat blend Expired - Fee Related CA2586946C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04026825.2 2004-11-11
EP04026825A EP1656839A1 (en) 2004-11-11 2004-11-11 Nutrition containing lipid blend
PCT/EP2005/012122 WO2006050975A1 (en) 2004-11-11 2005-11-11 Nutrition containing fat blend

Publications (2)

Publication Number Publication Date
CA2586946A1 CA2586946A1 (en) 2006-05-18
CA2586946C true CA2586946C (en) 2014-09-30

Family

ID=34927339

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2586946A Expired - Fee Related CA2586946C (en) 2004-11-11 2005-11-11 Nutrition containing fat blend

Country Status (18)

Country Link
US (2) US8053471B2 (https=)
EP (3) EP1656839A1 (https=)
JP (1) JP2008519796A (https=)
CN (2) CN102511818B (https=)
AT (1) ATE457656T1 (https=)
AU (1) AU2005303903B2 (https=)
BR (1) BRPI0517479B1 (https=)
CA (1) CA2586946C (https=)
DE (1) DE602005019452D1 (https=)
DK (1) DK1809125T3 (https=)
ES (1) ES2341355T3 (https=)
NZ (1) NZ554629A (https=)
PL (1) PL1809125T3 (https=)
PT (1) PT1809125E (https=)
RU (1) RU2402927C2 (https=)
SG (1) SG143274A1 (https=)
UA (1) UA89207C2 (https=)
WO (1) WO2006050975A1 (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1656839A1 (en) 2004-11-11 2006-05-17 N.V. Nutricia Nutrition containing lipid blend
EP1888081B1 (en) 2005-05-23 2016-12-28 Massachusetts Institute of Technology Compositions containing pufa and methods of use thereof
WO2007058523A1 (en) * 2005-11-17 2007-05-24 N.V. Nutricia Composition with docosapentaenoic acid
WO2008054192A1 (en) * 2006-11-02 2008-05-08 N.V. Nutricia Use of nutritional compositions for preventing disorders
ES2537080T3 (es) * 2005-12-23 2015-06-02 N.V. Nutricia Composición que comprende ácidos grasos poliinsaturados, proteínas y manganeso y/o molibdeno para mejorar la composición de membranas celulares
WO2008054193A1 (en) * 2006-11-02 2008-05-08 N.V. Nutricia Nutritional products that comprise saccharide oligomers
WO2009002145A1 (en) 2007-06-26 2008-12-31 N.V. Nutricia Lipid composition for improving function of brain functioning
ES2808406T3 (es) 2007-06-26 2021-02-26 Nutricia Nv Mejora de la memoria en sujetos con un mini examen del estado mental de 24-26
WO2009002148A1 (en) * 2007-06-27 2008-12-31 N.V. Nutricia Food composition for prodromal dementia patients
WO2009002146A1 (en) 2007-06-26 2008-12-31 N.V. Nutricia Supporting activities of daily living
CN100542411C (zh) * 2007-09-24 2009-09-23 张国浩 一种含ω-3多不饱和脂肪酸的营养均衡调和油及其生产方法
ES2697149T3 (es) 2007-12-20 2019-01-22 Nutricia Nv Producto líquido que contiene nucleótidos/nucleósidos
US20090264520A1 (en) * 2008-04-21 2009-10-22 Asha Lipid Sciences, Inc. Lipid-containing compositions and methods of use thereof
US9149452B2 (en) * 2009-04-20 2015-10-06 Women's & Children's Health Research Institute Inc. Methods and compositions for promoting the neurological development of an infant
JP5335601B2 (ja) * 2009-07-30 2013-11-06 ビーンスターク・スノー株式会社 栄養組成物
WO2012087113A1 (en) * 2010-12-24 2012-06-28 N.V. Nutricia Improved nutritional tablet
SG11201403712XA (en) * 2011-12-27 2014-10-30 Abbott Lab Use of reduced calorie infant formula containing nucleotides and/or carotenoids for reducing adverse health effects later in life
EP2861227A4 (en) 2012-06-17 2016-01-27 Matinas Biopharma Inc OMEGA-3 PENTAIC ACID COMPOSITIONS AND METHODS OF USE
CA2905671A1 (en) * 2013-03-13 2014-09-18 Matinas Biopharma Inc. Omega-3 pentaenoic acid compositions and methods of use
US8728546B1 (en) 2013-03-15 2014-05-20 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer, cardiovascular diseases and inflammation
FR3045069B1 (fr) * 2015-12-14 2019-01-25 Metabolium Procede d'enrichissement de protistes en lipides riches en acides gras polyinsatures, plus particulierement de classe omega 3, et sa mise en oeuvre pour la production de ces lipides
BR112018071493A2 (pt) * 2016-04-18 2019-02-19 N.V. Nutricia usos de ácido linoleico (la) e ácido alfa-linolênico (ala) na fabricação de uma composição nutricional, composição nutricional, método para prevenir declínio no funcionamento cognitivo induzido e método para prevenir redução na neurogênese induzida por estresse precoce
AU2018321407A1 (en) * 2017-08-25 2020-03-26 Struct Nutrition, Llc Compositions and methods for preventing, alleviating, and treating neurological injury following head trauma
MX2022005462A (es) * 2019-11-08 2022-05-26 Abbott Lab Exosomas en polvo aislados de la leche bovina, composiciones alimenticias y metodos.
WO2023232882A1 (en) 2022-05-31 2023-12-07 N.V. Nutricia Infant formula for improving cognitive development

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670285A (en) * 1982-08-06 1987-06-02 The University Of Toronto Innovations Foundation Infant formula
ES2033193B1 (es) 1990-10-30 1994-01-16 Ganadera Union Ind Agro Mezcla grasa para nutricion infantil y de adultos.
KR940003473A (ko) * 1992-08-14 1994-03-12 이순목 n-3 지방산이 축적된 우유 및 우유용 사료조성물
NL9401644A (nl) * 1994-10-06 1996-05-01 Friesland Brands Bv Voedingsmiddel voor zwangere en lacterende vrouwen
AU5346296A (en) * 1995-04-17 1996-11-07 Japan As Represented By Director-General Of Agency Of Industrial Science And Technology Novel microorganisms capable of producing highly unsaturated fatty acids and process for producing highly unsaturated fa tty acids by using the microorganisms
WO1996038051A1 (en) * 1995-05-30 1996-12-05 Suntory Limited Fowl eggs with high content of highly unsaturated fatty acids, process for producing the same, and use thereof
EP0843972B1 (en) * 1996-11-20 2002-07-31 N.V. Nutricia Nutritional composition comprising fats for the treatment of the metabolic syndrome
EP1039892B1 (en) * 1997-02-21 2004-04-28 Abbott Laboratories Use of polyunsaturated fatty acids for reducing the incidence of necrotizing enterocolitis
WO1998044917A1 (en) * 1997-03-27 1998-10-15 Bristol-Myers Squibb Company Use of docosahexanoic acid and arachidonic acid enhancing the growth of preterm infants
US6432684B1 (en) * 1997-04-11 2002-08-13 Abbott Laboratories Human desaturase gene and uses thereof
DE69718455T2 (de) * 1997-07-22 2003-04-30 Societe Des Produits Nestle S.A., Vevey Lipidzusammensetzung für Säuglingsnährpräparat und Herstellungsverfahren
AU6503699A (en) * 1998-10-05 2000-04-26 Abbott Laboratories Altered fatty acid biosynthesis in insect cells using delta five desaturase
US6495599B2 (en) * 2000-04-13 2002-12-17 Abbott Laboratories Infant formulas containing long-chain polyunsaturated fatty acids and uses therof
ITBO20000471A1 (it) 2000-07-31 2002-01-31 Vieri Ridolfi Dispositivo di supporto per prodotti da fumo particolarmente sigarette .
DE10057976B4 (de) 2000-11-22 2005-02-03 Südzucker AG Mannheim/Ochsenfurt Verfahren zur Herstellung von Pektinhydrolyseprodukten
AU2002309856B2 (en) * 2001-05-14 2008-10-23 Dsm Ip Assets B.V. Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsaturated fatty acids from microbes, genetically modified plant seeds and marine organisms
US20040209953A1 (en) * 2002-12-06 2004-10-21 Wai Lee Theresa Siu-Ling Glyceride compositions and methods of making and using same
GB0308104D0 (en) * 2003-04-08 2003-05-14 Novartis Nutrition Ag Organic compounds
EP1656839A1 (en) 2004-11-11 2006-05-17 N.V. Nutricia Nutrition containing lipid blend

Also Published As

Publication number Publication date
RU2402927C2 (ru) 2010-11-10
EP2191733A1 (en) 2010-06-02
PL1809125T3 (pl) 2010-07-30
CN102511818B (zh) 2014-12-24
AU2005303903B2 (en) 2012-05-31
EP1809125B1 (en) 2010-02-17
WO2006050975A1 (en) 2006-05-18
CN101052316B (zh) 2012-02-22
EP1809125A1 (en) 2007-07-25
CA2586946A1 (en) 2006-05-18
ES2341355T3 (es) 2010-06-18
SG143274A1 (en) 2008-06-27
UA89207C2 (ru) 2010-01-11
CN101052316A (zh) 2007-10-10
CN102511818A (zh) 2012-06-27
DK1809125T3 (da) 2010-06-07
BRPI0517479B1 (pt) 2015-06-09
US8053471B2 (en) 2011-11-08
EP1656839A1 (en) 2006-05-17
US8729123B2 (en) 2014-05-20
NZ554629A (en) 2010-09-30
BRPI0517479A (pt) 2008-10-07
RU2007121665A (ru) 2008-12-20
JP2008519796A (ja) 2008-06-12
DE602005019452D1 (de) 2010-04-01
US20120027885A1 (en) 2012-02-02
PT1809125E (pt) 2010-05-20
ATE457656T1 (de) 2010-03-15
AU2005303903A1 (en) 2006-05-18
US20080269330A1 (en) 2008-10-30

Similar Documents

Publication Publication Date Title
US8729123B2 (en) Nutrition containing fat blend
Lapillonne et al. Lipid needs of preterm infants: updated recommendations
Sanders Essential fatty acid requirements of vegetarians in pregnancy, lactation, and infancy
US20090054329A1 (en) Composition with docosapentaenoic acid
RU2558853C2 (ru) Эффекты метаболического импринтинга структурированных липидов
Lapillonne Enteral and parenteral lipid requirements of preterm infants
CA2729286C (en) Nutritional compositions containing punicalagins
Briend et al. Lipid intake in children under 3 years of age in France. A position paper by the Committee on Nutrition of the French Society of Paediatrics
Koletzko Trans Fatty Acids and the Human Infant¹
CN115104731B (zh) 营养组合物以及包含所述营养组合物的食品
Hendricks et al. Significance of milk fat in infant formulae
Mena et al. Fats
Delplanque et al. Brain docosahexaenoic acid (DHA) levels of young rats are related to alpha-linolenic acid (ALA) levels and fat matrix of the diet: impact of dairy fat
Scott Structured lipid: a functional ingredient to closely match infant formula to breast milk
Zhang et al. Health Effects of Docosahexanoic Acid (DHA)‒Enriched Eggs
Hamda et al. The Role of Dietary Docosahexaenoic Acid (DHA) for Cognitive Function
Hartmann et al. Longitudinal measures of visual acuity in full-term human infants fed different dietary fatty acids
Ghebremeskel et al. The role of essential fatty acids and antioxidants in neurovascular development and complications of prematurity
Freitas et al. DHAid™–The vegetarian source
Childs et al. Dietary Omega-3 Sources during Pregnancy and the Developing Brain: Lessons from Studies in Rats
CONNOR et al. Importance of Dietary Omega-3 Fatty Acids in Retinal Function

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20181113